Diarrhea News and Research

Latest Diarrhea News and Research

Combining inhibitor drug with immunotherapy agent improves response in cancer patients

Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.

16 Aug 2021

CDC gives a food safety alert regarding outbreak of Salmonella infections

A CDC food safety alert regarding a multistate outbreak of Salmonella Enteritidis infections has been posted: https://www.cdc.gov/salmonella/enteritidis-06-21/index.html

11 Aug 2021

Long COVID may be due to persistent immune disturbances

A new study discusses abnormalities in the immune response following COVID-19 in samples collected from patients who have recovered from COVID-19.

8 Aug 2021

FDA approves an intravenous medication to treat patients with Pompe disease

Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.

6 Aug 2021

Antibiotic-resistant salmonella bacteria packs a punch for U.S. travelers

One type of the salmonella bacteria is much more likely to cause disease and fend off frontline antibiotics when acquired in Europe, Asia, and parts of Africa rather than domestically in the United States.

2 Aug 2021

Diabetes drug’s new weight loss formula fuels cost-benefit debate

The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people — especially those with Type 2 diabetes, which is associated with obesity — may desperately want.

30 Jul 2021

Vitamin D supplements are not effective for easing painful IBS symptoms, study reveals

Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.

29 Jul 2021

Want fries with that vaccine? Even at a fast-food restaurant, pop-up clinics see slow traffic

A few months ago, the boxy, teal truck parked outside a McDonald's in this Inland Empire city might have drawn hundreds of people willing to stand in line for hours under the scorching sun.

27 Jul 2021

Global economic recovery at risk due to COVID-19 vaccine inequity

New Global Dashboard on COVID-19 Vaccine Equity finds low-income countries would add $38 billion to their GDP forecast for 2021 if they had the same vaccination rate as high-income countries. Global economic recovery at risk if vaccines are not equitably manufactured, scaled up and distributed.

23 Jul 2021

UMass Amherst Ph.D. candidate receives USDA-NIFA fellowship for food allergy research

University of Massachusetts Amherst food science Ph.D. candidate Cassandra Suther has received a prestigious predoctoral fellowship of $180,000 from the U.S. Department of Agriculture's National Institute of Food and Agriculture (USDA-NIFA) to study the effect of norovirus on the development and severity of food allergies.

23 Jul 2021

Intestinal organoids demonstrate variability in SARS-CoV-2 susceptibility

Three-dimensional organoid structures grown in the lab allow deeper, almost in situ investigation of a biological system, without the use of living animals. In a paper recently uploaded to the preprint server bioRxiv*, organoids generated from human specimens are utilized to investigate the way in which SARS-CoV-2 interacts with the numerous cells of the intestinal epithelium, finding great heterogeneity in the susceptibility of the organoids and the cells within to infection.

21 Jul 2021

$40 million multi-year study to examine long-term impacts of COVID-19 and MIS-C

Up to 2,000 children and young adults will be enrolled in a study from Children's National Hospital in collaboration with the National Institute of Allergy and Infectious Diseases that will examine the long-term effects of COVID-19 and multisystem inflammatory syndrome in children (MIS-C) after these patients have recovered from a COVID-19 infection.

20 Jul 2021

Study finds dramatic decreases in antibiotic dispensing for children during the pandemic

As children made fewer visits to health facilities and engaged in social distancing and other COVID-19 mitigation measures, a smaller number of them also received prescription drugs, a new study suggests.

20 Jul 2021

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.

20 Jul 2021

Study reveals pathological mechanism and treatment strategy of pre-engraftment syndrome

The research team led by Prof. WEI Haiming and Prof. TIAN Zhigang from Division of Life Sciences and Medicine, University of Science and Technology of China of the Chinese Academy of Sciences, collaborating with the research group led by Prof. SUN Zimin from the First Affiliated Hospital of USTC revealed the pathological mechanism of severe pre-engraftment syndrome (PES) after umbilical cord blood transplantation, not only providing a treatment strategy for patients with PES, but significantly guiding for further improvement in the curative effect of unrelated cord blood transplantation (UCBT).

19 Jul 2021

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Researchers at Vanderbilt University Medical Center and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.

16 Jul 2021

Review details clinical signs of SARS-CoV-2 infection in domestic and wild cats

Now, a new systematic review has been published in the journal Animals that focuses on the clinical symptoms in felines diagnosed with SARS-CoV-2 worldwide.

13 Jul 2021

How do host factors like the lung microbiome aid in SARS‐CoV‐2 infection?

A new article has been published in Cellular and Molecular Lifesciences, which focuses on the connection between host factors and the worsening of the COVID-19. Further, the impact of the virus on the host’s microbiome and secondary infection has also been studied.

8 Jul 2021

New drug can significantly reduce flashbacks and nightmares in PTSD patients

Post-traumatic stress disorder (PTSD) rings a bell for many, due to its rampant references in pop culture, and more, importantly, its prevalence in today's society. It is only probable that this disorder, which develops after shocking or dangerous events, would unfortunately affect the lives of many people.

7 Jul 2021

Long-term exposure to air pollutants increases the risk of dysmenorrhea in women

Dysmenorrhea, that is, frequent severe and painful cramps during menstruation from abnormal contractions of the uterus, is the most common of all gynecological disorders. It affects between 16-91% of girls and women of reproductive age, of whom 2%-29% have symptoms severe enough to restrict their daily activity.

6 Jul 2021

Diarrhea News and Research

Latest Diarrhea News and Research

Combining inhibitor drug with immunotherapy agent improves response in cancer patients

CDC gives a food safety alert regarding outbreak of Salmonella infections

Long COVID may be due to persistent immune disturbances

FDA approves an intravenous medication to treat patients with Pompe disease

Antibiotic-resistant salmonella bacteria packs a punch for U.S. travelers

Diabetes drug’s new weight loss formula fuels cost-benefit debate

Vitamin D supplements are not effective for easing painful IBS symptoms, study reveals

Want fries with that vaccine? Even at a fast-food restaurant, pop-up clinics see slow traffic

Global economic recovery at risk due to COVID-19 vaccine inequity

UMass Amherst Ph.D. candidate receives USDA-NIFA fellowship for food allergy research

Intestinal organoids demonstrate variability in SARS-CoV-2 susceptibility

$40 million multi-year study to examine long-term impacts of COVID-19 and MIS-C

Study finds dramatic decreases in antibiotic dispensing for children during the pandemic

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Study reveals pathological mechanism and treatment strategy of pre-engraftment syndrome

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Review details clinical signs of SARS-CoV-2 infection in domestic and wild cats

How do host factors like the lung microbiome aid in SARS‐CoV‐2 infection?

New drug can significantly reduce flashbacks and nightmares in PTSD patients

Long-term exposure to air pollutants increases the risk of dysmenorrhea in women

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Diarrhea News and Research

Latest Diarrhea News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in